Dr. Gabriel M Cohn MD
Geneticist | Clinical Genetics (M.D.)
759 CHESTNUT ST SPRINGFIELD MA, 01199About
Dr. Gabriel Cohn practices Genetic Medicine in SPRINGFIELD, MA. As a geneticist, Dr. Cohn performs experiments and analyzes data to interpret the inheritance of different traits in patients. A geneticist evaluates, diagnoses, and manages patients with hereditary conditions or congenital malformations, genetic risk calculations, and mutation analysis. Dr. Cohn carries out studies, tests, and counsels patients with genetic diseases.
Education and Training
Suny-Hlth Sci Ctr At Syracuse, Coll of Med, Syracuse Ny 1986
Upstate Medical University/ College of Health Professions 1986
Board Certification
Medical GeneticsAmerican Board of Medical GeneticsABMG
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Spontaneous conversion to estrogen receptor expression by the human breast epithelial cell line, MCF-10A.
- An antibody assay predictive of BRCA1 mutations in ovarian tumors and normal tissue.
- Immunohistochemical analysis of BRCA2 expression in normal human buccal cells.
- A rapid immunoassay predicts BRCA1 and BRCA2 mutations in buccal cells.
- Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the beta-myosin heavy chain gene. A 908Leu----Val mutation and a 403Arg----Gln mutation.
- Efficacy of rectal misoprostol as second-line therapy for the treatment of primary postpartum hemorrhage.
- Osteopathies encountered in the endocrine clinic.
- Testosterone therapy in a case of fibrous dysplasia of bone with hypogenitalism.
- The oral administration of methyl testosterone in a male castrate.
- Testosterone therapy in a case of fibrous dysplasia of bone with hypogenitalism.
- Phase 1/2 and extension study of velaglucerase alfa replacement therapy in adults with type 1 Gaucher disease: 48-month experience.
- Testosterone in a case of polyostotic fibrous dysplasia.
- Early achievement and maintenance of the therapeutic goals using velaglucerase alfa in type 1 Gaucher disease.
- Significant and continuous improvement in bone mineral density among type 1 Gaucher disease patients treated with velaglucerase alfa: 69-month experience, including dose reduction.
- Development of a mnemonic screening tool for identifying subjects with Hunter syndrome.
Dr. Gabriel M Cohn MD's Practice location
SPRINGFIELD, MA 01199Get Direction
Dr. Gabriel M Cohn MD's reviews
Write ReviewRecommended Articles
- Different Types of Physicians Explained
Doctors or physicians are categorized according to different factors including medical specialties and subspecialties. Most doctors specialize in a specific area of medicine. This article provides a summary of the different types of doctors in the medical field. AllergistsAllergists are also...
- The Most Common Misconceptions About Breast Cancer
There is so much information you can read online about breast cancer. Some information may be acquired in the community, friends, or family that is totally misleading or incorrect. Although not backed up with solid evidence, such information can cause a lot of media attention, which can further...
- Adalia Rose
OverviewAdalia Rose is an American internet star. She was born with Hutchinson-Gilford progeria syndrome, which is a premature aging disease. This genetic condition is also commonly known as progeria. During her early infancy stage, her body was much older than the normal age. In spite of her...
- What Is Pituitary Dwarfism?
IntroductionPituitary dwarfism, also called growth hormone deficiency, is a medical condition wherein the pituitary gland does not produce sufficient amounts of growth hormone. This deficiency often results in children’s slow growth or short stature.An adult with pituitary dwarfism has an average...
- Is My Child More Likely to Develop Autism if a Blood Relative Has Autism?
Autism characterized by impaired social interactions reduced verbal and non-verbal communication and stereotyped behavior and activities. These symptoms appear in early childhood and impair or limit everyday functioning.Autism and geneticsResearchers believe that both environment and genetics play a...
- What is Neurofibromatosis?
Neurofibromatosis is a genetic disorder that affects the development of nerve cells and tissues in the body, leading to the formation of tumors in different parts of the nervous system. These tumors, also known as neurofibromas, may develop in the brain, spinal cord, along the nerves, or under the...
Nearby Providers
- Dr. Matthew R Fickie MD759 Chestnut Street Springfield MA 01199
- Dr. Mary-alice Abbott MD759 Chestnut St Springfield MA 01199